Apolipoprotein E-genotypes in patients investigated for dementia;Apolipoprotein E-genotyper hos patienter udredt for demens

Ugeskrift for Laeger

Volumn 159, Issue 38, 1997, Pages 5658-5661

  Johannsen, Peter ^a   Jakobsen, Johannes K ^b   Jørgensen, Arne Lund ^b  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E;

ALLELE; ALZHEIMER DISEASE; ARTICLE; DEMENTIA; DENMARK; GENE FREQUENCY; GENETICS; GENOTYPE; HUMAN; RISK FACTOR;

ALLELES; ALZHEIMER DISEASE; APOLIPOPROTEINS E; DEMENTIA; DENMARK; GENE FREQUENCY; GENOTYPE; HUMANS; RISK FACTORS;

EID: 0031571898     PISSN: 00415782     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Jørgensen AL, Johannsen P. Alzheimers sygdom og generne. Ugeskr Læger 1997; 159: 5648-52.
2. Gerdes LU, Klausen IC, Sihm I, Færgeman O. Apolipoprotein E polymorphism in a Danish population compared to findings in 45 other study populations around the World. Genet Epidemiol 1992; 9: 155-67.
3. Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC Jr., Small GW et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 1993; 261: 921-3.
4. Saunders AM, Strittmatter WJ, Schmechel DE, St.George-Hyslop PH, Pericak-Vance MA, Joo SH et al. Association of apolipoprotein E allele ε4 with late-onset familial and sporadic Alzheimer's disease. Neurology 1993; 43: 1467-72.
5. Corder EH, Saunders AM, Risch NJ, Strittmatter WJ, Schmechel DE, Gaskell PC Jr. et al. Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease. Nature Genet 1994; 7: 180-4.
6. Van Duijn CM, de Knijff P, Wehnert A, De Voecht J, Bronzova JB, Havekes LM et al. The apolipoprotein E epsilon 2 allele is associated with an increased risk of early-onset Alzheimer's disease and a reduced survival. Ann Neurol 1995; 37: 605-10.
7. Saunders AM, Hulette C, Welsh-Bohmer KA, Schmechel DE, Crain B, Burke JR et al. Specificity, sensitivity, and predictive value of apolipoprotein-E genotyping for sporadic Alzheimer's disease. Lancet 1996; 348: 90-3.
8. Talbot C, Lendon C, Craddock N, Shears S, Morris JC, Goate A. Protection against Alzheimer's disease with apoE epsilon 2. Lancet 1994; 343: 1432-3.
9. Johannsen P, Ehlers L, Abelskov K, Gulmann NC, Christensen T, Gjedde A et al. Klinik for demensudredning -110 konsekutive patienter. Ugeskr Læger 1997; 159: 1246-51.
10. Sambrook J, Fritsch EF, Maniatis T. Molecular cloning. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1989.
11. Hixson JE, Vernier DT. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res 1990; 31: 545-8.
12. Schachter F, Faure-Delanef L, Guenot F, Rouger H, Froguel P, Lesueur-Ginot L et al. Genetic associations with human longevity at the APOE and ACE loci. Nature Genet 1994; 6: 29-32.
13. Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC Jr., Rimmler JB et al. Apolipoprotein E, survival in Alzheimer's disease patients, and the competing risks of death and Alzheimer's disease. Neurology 1995; 45: 1323-8.
14. Sobel E, Louhija J, Sulkava R, Davanipour Z, Kontula K, Miettinen H et al. Lack of association of apolipoprotein E allele epsilon 4 with late-onset Alzheimer's disease among Finnish centenarians. Neurology 1995; 45: 903-7.
15. Wilson PW, Myers RH, Larson MG, Ordovas JM, Wolf PA, Schaefer EJ. Apolipoprotein E alleles, dyslipidemia, and coronary heart disease. The Framingham Offspring Study. JAMA 1994; 272: 1666-71.
16. Frisoni GB, Bianchetti A, Govoni S, Trabucchi M, Calabresi L, Franceschini G. Association of apolipoprotein E E4 with vascular dementia. JAMA 1994; 271: 1317.
17. Roses AD, Saunders AM, Alberts MA, Strittmatter WJ, Schmechel DE, Gorder E et al. Apolipoprotein E E4 allele and risk of dementia. JAMA 1995; 273: 374-5.
18. National Institute on Aging/Alzheimer's Association Working Group. Apolipoprotein E genotyping in Alzheimer's disease. Lancet 1996; 347: 1091-5.
19. Writing Committee Lancet Conference 1996. The challenge of the dementias. Lancet 1996; 347: 1303-7.